GlassScriptPhysician profile
Mehak Kapoor
NPI 1235691932
$10,790.15
in general payments reported to CMS, 2019-2025
14 companies · $6,668 in 2025
The $6,668 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $378 · 2023: $1,394 · 2024: $2,351 · 2025: $6,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,886 · Food and Beverage: $2,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,885.64 |
| Food and Beverage | $2,526.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $8,801.72 | 2023-2025 | Rivacor 7 Dr-T, Edora 8 Dr-T |
| Astrazeneca Pharmaceuticals LP | $414.57 | 2021-2024 | |
| Boston Scientific Corporation | $301.01 | 2023-2024 | Watchman Flx |
| Amgen INC. | $274.34 | 2023-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $226.07 | 2024-2025 | |
| Abbott Laboratories | $196.35 | 2024-2025 | Cardiomems, Assurity |
| Lantheus Medical Imaging, INC. | $138.06 | 2023-2025 | Definity |
| Pfizer INC. | $134.89 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.12 | 2023-2024 | Jardiance |
| Biosense Webster, INC. | $71.31 | 2024 | Qdot Micro Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $46.44 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $42.20 | 2024-2025 | Eliquis, Camzyos |
| Chiesi USA, INC. | $19.76 | 2023 | Cleviprex, Kengreal |
| Lexicon Pharmaceuticals, INC. | $14.31 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehak Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.